Karmanos Cancer Institute Researchers Combine Treatments to Provide Better ... - PR Newswire (press release) Print
PR Newswire (press release)Dr. Abidi has led a two-part Phase I dose escalation study that enrolled patients with multiple myeloma with normal and abnormal renal function.

... read more